Myst Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Myst Therapeutics General Information

Description

Operator of a biotechnology company focused on advancing novel T-cell therapies for solid tumors. The company specializes in the commercialization of novel broad-spectrum cancer immunotherapy products. enabling the patient's own immune system to destroy cancer cells and to develop an adoptive cell therapy utilizing enriched t cells from tumors and peripheral blood that target a broad spectrum of cancer mutations.

Contact Information

Website
www.myst-tx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 570 Westwood Plaza
  • Cnsi Building 114
  • Los Angeles, CA 90095
  • United States
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 570 Westwood Plaza
  • Cnsi Building 114
  • Los Angeles, CA 90095
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Myst Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 20-Jan-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Myst Therapeutics’s complete valuation and funding history, request access »

Myst Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company focused on advancing novel T-cell therapies for solid tumors. The company specialize
Biotechnology
Los Angeles, CA

Waltham, MA
 

Somerville, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Myst Therapeutics Competitors (73)

One of Myst Therapeutics’s 73 competitors is TScan Therapeutics, a Formerly VC-backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TScan Therapeutics Formerly VC-backed Waltham, MA
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Instil Bio Formerly VC-backed Dallas, TX
Kite Pharma Formerly VC-backed Santa Monica, CA
Allogene Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 73 competitors. Get the full list »

Myst Therapeutics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dreamers VC Venture Capital Minority
Magnify Accelerator/Incubator
To view Myst Therapeutics’s complete investors history, request access »

Myst Therapeutics FAQs

  • When was Myst Therapeutics founded?

    Myst Therapeutics was founded in 2019.

  • Where is Myst Therapeutics headquartered?

    Myst Therapeutics is headquartered in Los Angeles, CA.

  • What industry is Myst Therapeutics in?

    Myst Therapeutics’s primary industry is Biotechnology.

  • Is Myst Therapeutics a private or public company?

    Myst Therapeutics is a Private company.

  • What is Myst Therapeutics’s current revenue?

    The current revenue for Myst Therapeutics is .

  • Who are Myst Therapeutics’s investors?

    Dreamers VC and Magnify have invested in Myst Therapeutics.

  • Who are Myst Therapeutics’s competitors?

    TScan Therapeutics, Genetix Biotherapeutics, Instil Bio, Kite Pharma, and Allogene Therapeutics are some of the 73 competitors of Myst Therapeutics.

  • When was Myst Therapeutics acquired?

    Myst Therapeutics was acquired on 20-Jan-2021.

  • Who acquired Myst Therapeutics?

    Myst Therapeutics was acquired by Turnstone Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process